BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 30 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 500,000 | $1,881,000 | 0.06% |
AJU IB Investment Co., Ltd. | 25,651 | $96,000 | 0.04% |
BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $199,000 | 0.01% |
Baker Brothers Advisors | 249,123 | $937,000 | 0.00% |
SHUFRO ROSE & CO LLC | 12,941 | $49,000 | 0.00% |
Squarepoint Ops LLC | 27,915 | $105,000 | 0.00% |
Tekla Capital Management LLC | 6,000 | $23,000 | 0.00% |
Orion Capital Management LLC | 500 | $2,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 13,300 | $50,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 26 | $0 | 0.00% |